SCHEMBL25196241

SCHEMBL25196241

CC(C)(C)c1ccccc1Nc1ccc(CNO)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.49
▸ THRB P10828 2/20 0.49
▸ POLB P06746 1/20 0.49
▸ ALOX12 P18054 1/20 0.49
▸ IDO1 P14902 2/20 0.44
▸ P2RY1 P47900 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ GRIN2D O15399 1/20 0.37
▸ GRIN3B O60391 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2A Q12879 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ GRIN2C Q14957 1/20 0.37
▸ GRIN3A Q8TCU5 1/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MT-CO2 P00403 1/20 0.37
▸ SIRT2 Q8IXJ6 1/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8962199 0.77 TDP1 (0.50) GAATHRBPOLBALOX12P2RY1
SCHEMBL9703296 0.76 P2RY1 (0.42) GAATHRBPOLBALOX12P2RY1
SCHEMBL28793668 0.75 PTGER4 (0.42) GAATHRBPOLBALOX12IDO1
SCHEMBL25183891 0.75 CA1 (0.49) —
SCHEMBL28698942 0.75 MAPT (0.58) GAATHRBPOLBALOX12P2RY1
SCHEMBL25195421 0.74 IDO1 (0.67) GAATHRBPOLBALOX12IDO1
SCHEMBL25187821 0.74 RIPK1 (0.45) GAATHRBPOLBALOX12IDO1
SCHEMBL2818765 0.73 ALDH1A1 (0.48) GAATHRBPOLBALOX12IDO1
SCHEMBL29499693 0.73 ALDH1A1 (0.48) GAATHRBPOLBALOX12IDO1
SCHEMBL25204894 0.73 CFTR (0.36) GAATHRBIDO1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151252-B Iron death inhibitor-diarylamine acetamides 维泰瑞隆有限公司 2024-08-27 — — CN disclosed
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES Sironax Ltd. (KY) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159492-A1 FERROPTOSIS INHIBITORS - DIARYLAMINE PARA-ACETAMIDES AIFM2, FECH, GPX4 GAA 4193/4885THRB 4031/4885POLB 4641/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback